(+)-artemisinic acid decreases expression ISO RGD:737118 6480464 artemisic acid results in decreased expression of KITLG mRNA CTD PMID:23063590 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions ISO RGD:3086 6480464 2 more ... CTD PMID:19414516 1,1-dichloroethene decreases expression EXP 6480464 vinylidene chloride results in decreased expression of KITL mRNA CTD PMID:26682919 1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of KITL mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:3086 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in increased expression of KITLG mRNA CTD PMID:27840820 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of KITL mRNA CTD PMID:22206623 1,4-benzoquinone increases expression ISO RGD:737118 6480464 quinone results in increased expression of KITLG mRNA CTD PMID:22960397 1-chloro-2,4-dinitrobenzene decreases expression EXP 6480464 Dinitrochlorobenzene results in decreased expression of KITL mRNA CTD PMID:21404309 1-octadec-9-enoylglycero-3-phosphate multiple interactions ISO RGD:737118 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein] more ... CTD PMID:21915944 17alpha-ethynylestradiol decreases expression ISO RGD:3086 6480464 Ethinyl Estradiol results in decreased expression of KITLG mRNA CTD PMID:17557909 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of KITL mRNA CTD PMID:22467019 17beta-estradiol multiple interactions ISO RGD:3086 6480464 [Estradiol co-treated with bisphenol A] results in decreased expression of KITLG mRNA CTD PMID:27174447 17beta-estradiol multiple interactions EXP 6480464 BMPR2 protein modified form inhibits the reaction [KITLG protein inhibits the reaction [FSHB protein results in increased abundance of Estradiol]] more ... CTD PMID:22366471 17beta-estradiol increases expression ISO RGD:737118 6480464 Estradiol results in increased expression of KITLG mRNA CTD PMID:19167446 17beta-estradiol decreases expression ISO RGD:737118 6480464 Estradiol results in decreased expression of KITLG mRNA CTD PMID:21185374 , PMID:31614463 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:737118 6480464 Dihydrotestosterone results in increased expression of KITLG mRNA, Dihydrotestosterone results in increased expression of KITLG protein CTD PMID:15953861 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:737118 6480464 2 more ... CTD PMID:23146750 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:3086 6480464 [Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] which results in decreased expression of KITL mRNA CTD PMID:21602191 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:3086 6480464 Tetrachlorodibenzodioxin results in decreased expression of KITLG mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of KITL mRNA CTD PMID:18691609 , PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:3086 6480464 Tetrachlorodibenzodioxin affects the expression of KITLG mRNA CTD PMID:22298810 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737118 6480464 Tetrachlorodibenzodioxin results in increased expression of KITLG mRNA CTD PMID:21296121 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of KITL mRNA CTD PMID:19770486 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:3086 6480464 Trinitrobenzenesulfonic Acid results in increased expression of KITLG mRNA CTD PMID:17385238 2,4-diaminotoluene increases expression EXP 6480464 2, 4-diaminotoluene results in increased expression of KITL mRNA CTD PMID:20713471 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:3086 6480464 3 more ... CTD PMID:23196670 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of KITL mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of KITL mRNA CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:737118 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KITLG mRNA CTD PMID:28628672 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of KITL mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of KITL mRNA CTD PMID:30951980 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression EXP 6480464 Oxazolone results in decreased expression of KITL mRNA CTD PMID:21404309 4-hydroxynon-2-enal increases expression EXP 6480464 4-hydroxy-2-nonenal results in increased expression of KITL mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of KITLG mRNA CTD PMID:28973697 5-fluorouracil increases expression ISO RGD:737118 6480464 Fluorouracil results in increased expression of KITLG mRNA CTD PMID:19098008 7,12-dimethyltetraphene increases expression ISO RGD:3086 6480464 9 more ... CTD PMID:24576726 acrylamide decreases expression ISO RGD:3086 6480464 Acrylamide results in decreased expression of KITLG mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:737118 6480464 Aflatoxin B1 affects the expression of KITLG protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:737118 6480464 Aflatoxin B1 results in increased expression of KITLG mRNA CTD PMID:21632981 , PMID:21641981 aflatoxin M1 decreases expression ISO RGD:737118 6480464 Aflatoxin M1 results in decreased expression of KITLG mRNA CTD PMID:30928695 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of KITL mRNA CTD PMID:16505366 all-trans-retinoic acid increases expression ISO RGD:737118 6480464 Tretinoin results in increased expression of KITLG mRNA CTD PMID:21934132 all-trans-retinoic acid multiple interactions EXP 6480464 AGN 193109 inhibits the reaction [Tretinoin results in increased expression of KITL mRNA] CTD PMID:16505366 allethrin decreases expression ISO RGD:3086 6480464 Allethrins results in decreased expression of KITLG mRNA CTD PMID:28181402 allethrin multiple interactions ISO RGD:3086 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of KITLG mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of KITLG mRNA CTD PMID:33051911 , PMID:33396045 amiodarone increases expression ISO RGD:737118 6480464 Amiodarone results in increased expression of KITLG mRNA CTD PMID:19774075 ammonium chloride affects expression ISO RGD:3086 6480464 Ammonium Chloride affects the expression of KITLG mRNA CTD PMID:16483693 ammonium hexachloroplatinate affects expression ISO RGD:737118 6480464 ammonium hexachloroplatinate affects the expression of KITLG mRNA CTD PMID:19110044 antirheumatic drug increases expression ISO RGD:737118 6480464 Antirheumatic Agents results in increased expression of KITLG mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:737118 6480464 aristolochic acid I results in decreased expression of KITLG mRNA CTD PMID:33212167 arsane decreases expression EXP 6480464 Arsenic results in decreased expression of KITL mRNA CTD PMID:19654921 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of KITL mRNA CTD PMID:19654921 arsenous acid decreases expression ISO RGD:737118 6480464 Arsenic Trioxide results in decreased expression of KITLG mRNA CTD PMID:15761015 arsenous acid decreases response to substance ISO RGD:737118 6480464 KITLG protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:16360329 arsenous acid increases expression ISO RGD:737118 6480464 Arsenic Trioxide results in increased expression of KITLG mRNA CTD PMID:20458559 , PMID:26705709 atrazine multiple interactions ISO RGD:3086 6480464 Quercetin inhibits the reaction [Atrazine results in decreased expression of KITLG mRNA] CTD PMID:22372587 atrazine decreases expression ISO RGD:3086 6480464 Atrazine results in decreased expression of KITLG mRNA CTD PMID:22372587 benzene increases expression ISO RGD:737118 6480464 Benzene results in increased expression of KITLG mRNA CTD PMID:22960397 benzo[a]pyrene increases expression ISO RGD:737118 6480464 Benzo(a)pyrene results in increased expression of KITLG mRNA CTD PMID:20106945 , PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:737118 6480464 Benzo(a)pyrene affects the methylation of KITLG promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KITL mRNA CTD PMID:27858113 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of KITL mRNA CTD PMID:22610609 benzo[a]pyrene decreases expression ISO RGD:737118 6480464 Benzo(a)pyrene results in decreased expression of KITLG mRNA CTD PMID:22316170 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of KITL mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:737118 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene decreases expression EXP 6480464 benzo(b)fluoranthene results in decreased expression of KITL mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KITL mRNA CTD PMID:27858113 benzophenanthridine decreases expression ISO RGD:737118 6480464 Benzophenanthridines analog results in decreased expression of KITLG mRNA CTD PMID:23117580 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of KITL mRNA CTD PMID:29385306 bisphenol A affects expression ISO RGD:3086 6480464 bisphenol A affects the expression of KITLG mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of KITL mRNA CTD PMID:30951980 bisphenol A multiple interactions ISO RGD:737118 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of KITLG gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KITLG mRNA CTD PMID:28628672 , PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of KITL mRNA CTD PMID:28393075 bisphenol A multiple interactions ISO RGD:3086 6480464 [Estradiol co-treated with bisphenol A] results in decreased expression of KITLG mRNA CTD PMID:27174447 bisphenol A decreases expression ISO RGD:3086 6480464 bisphenol A results in decreased expression of KITLG mRNA CTD PMID:27174447 , PMID:34947998 bisphenol A increases expression ISO RGD:3086 6480464 bisphenol A results in increased expression of KITLG mRNA CTD PMID:27208089 more ... bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of KITL mRNA CTD PMID:30951980 butanal decreases expression ISO RGD:737118 6480464 butyraldehyde results in decreased expression of KITLG mRNA CTD PMID:26079696 butyric acid increases expression ISO RGD:737118 6480464 Butyric Acid results in increased expression of KITLG mRNA CTD PMID:17928716 cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which affects the splicing of KITL mRNA CTD PMID:28892167 cadmium dichloride decreases expression ISO RGD:3086 6480464 Cadmium Chloride results in decreased expression of KITLG mRNA, Cadmium Chloride results in decreased expression of KITLG protein CTD PMID:24462979 , PMID:28801138 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which affects the splicing of KITL mRNA CTD PMID:28892167 cadmium dichloride multiple interactions ISO RGD:737118 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of KITLG protein] CTD PMID:26138014 cadmium dichloride increases secretion ISO RGD:737118 6480464 Cadmium Chloride results in increased secretion of KITLG protein CTD PMID:26138014 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of KITL mRNA CTD PMID:24982889 calcitriol decreases expression ISO RGD:737118 6480464 Calcitriol results in decreased expression of KITLG mRNA CTD PMID:16002434 carbamazepine affects expression ISO RGD:737118 6480464 Carbamazepine affects the expression of KITLG mRNA CTD PMID:25979313 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:737118 6480464 Nanotubes, Carbon analog results in increased expression of KITLG mRNA CTD PMID:25102311 ceric oxide increases expression ISO RGD:737118 6480464 ceric oxide analog results in increased expression of KITLG mRNA CTD PMID:24821434 chloroprene increases expression ISO RGD:3086 6480464 Chloroprene results in increased expression of KITLG mRNA CTD PMID:23125180 cholesterol increases expression ISO RGD:737118 6480464 Cholesterol results in increased expression of KITLG mRNA CTD PMID:26296894 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of KITL gene CTD PMID:20938992 chrysene decreases expression EXP 6480464 chrysene results in decreased expression of KITL mRNA CTD PMID:26377693 chrysene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KITL mRNA CTD PMID:27858113 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of KITLG mRNA CTD PMID:21151649 cisplatin multiple interactions ISO RGD:737118 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of KITLG mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:737118 6480464 Cisplatin results in increased expression of KITLG mRNA CTD PMID:27392435 copper atom multiple interactions ISO RGD:737118 6480464 [Chelating Agents binds to Copper] which results in increased expression of KITLG mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:737118 6480464 [Chelating Agents binds to Copper] which results in increased expression of KITLG mRNA CTD PMID:30911355 Cuprizon decreases expression ISO RGD:3086 6480464 Cuprizone results in decreased expression of KITLG mRNA CTD PMID:27523638 cyclophosphamide affects expression EXP 6480464 Cyclophosphamide affects the expression of KITL mRNA CTD PMID:12624490 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of KITL mRNA CTD PMID:12662436 cyclophosphamide multiple interactions EXP 6480464 [Cyclophosphamide co-treated with Sizofiran] results in increased expression of KITL mRNA CTD PMID:10052129 cyhalothrin multiple interactions ISO RGD:3086 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of KITLG mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of KITLG mRNA CTD PMID:33051911 , PMID:33396045 cypermethrin multiple interactions ISO RGD:3086 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of KITLG mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of KITLG mRNA CTD PMID:33051911 , PMID:33396045 daidzein multiple interactions ISO RGD:737118 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KITLG mRNA CTD PMID:27424125 daidzein 7-O-beta-D-glucoside multiple interactions ISO RGD:737118 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KITLG mRNA CTD PMID:27424125 daunorubicin decreases expression ISO RGD:3086 6480464 Daunorubicin results in decreased expression of KITLG mRNA CTD PMID:27090888 deoxynivalenol increases expression ISO RGD:737118 6480464 deoxynivalenol results in increased expression of KITLG mRNA CTD PMID:27757495 , PMID:31863870 dexamethasone multiple interactions EXP 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of KITL mRNA CTD PMID:16054899 dexamethasone multiple interactions ISO RGD:737118 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KITLG mRNA CTD PMID:28628672 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of KITL mRNA CTD PMID:21041162 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KITL mRNA CTD PMID:29950665 diarsenic trioxide decreases expression ISO RGD:737118 6480464 Arsenic Trioxide results in decreased expression of KITLG mRNA CTD PMID:15761015 diarsenic trioxide increases expression ISO RGD:737118 6480464 Arsenic Trioxide results in increased expression of KITLG mRNA CTD PMID:20458559 , PMID:26705709 diarsenic trioxide decreases response to substance ISO RGD:737118 6480464 KITLG protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:16360329 diazinon increases expression ISO RGD:3086 6480464 Diazinon results in increased expression of KITLG mRNA CTD PMID:29108742 dibutyl phthalate decreases expression ISO RGD:3086 6480464 Dibutyl Phthalate results in decreased expression of KITLG mRNA CTD PMID:21745491 dibutyl phthalate increases expression ISO RGD:3086 6480464 Dibutyl Phthalate results in increased expression of KITLG protein CTD PMID:21745491 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of KITL mRNA CTD PMID:15591538 diuron decreases expression ISO RGD:3086 6480464 Diuron results in decreased expression of KITLG mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:737118 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO RGD:737118 6480464 Doxorubicin affects the expression of KITLG mRNA CTD PMID:25529476 doxorubicin increases expression ISO RGD:737118 6480464 Doxorubicin results in increased expression of KITLG mRNA CTD PMID:30031762 endosulfan decreases expression ISO RGD:3086 6480464 Endosulfan results in decreased expression of KITLG mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:737118 6480464 entinostat results in increased expression of KITLG mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:737118 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KITLG mRNA CTD PMID:27188386 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of KITL mRNA CTD PMID:35436446 erlotinib hydrochloride multiple interactions ISO RGD:737118 6480464 [Gemcitabine co-treated with Erlotinib Hydrochloride] affects the expression of KITLG protein CTD PMID:24979617 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of KITL mRNA CTD PMID:30319688 ethanol affects expression EXP 6480464 Ethanol affects the expression of KITL mRNA CTD PMID:30319688 fenvalerate increases expression ISO RGD:3086 6480464 fenvalerate results in increased expression of KITLG mRNA CTD PMID:30307764 fenvalerate multiple interactions ISO RGD:3086 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of KITLG mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of KITLG mRNA CTD PMID:33051911 , PMID:33396045 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of KITL gene CTD PMID:20938992 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of KITL mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO RGD:737118 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of KITLG gene CTD PMID:31601247 fumonisin B1 decreases expression ISO RGD:737118 6480464 fumonisin B1 results in decreased expression of KITLG mRNA CTD PMID:27757495 furan increases expression ISO RGD:3086 6480464 furan results in increased expression of KITLG mRNA CTD PMID:27387713 gadodiamide hydrate increases expression ISO RGD:3086 6480464 gadodiamide results in increased expression of KITLG protein CTD PMID:20938346 gemcitabine decreases expression ISO RGD:737118 6480464 Gemcitabine results in decreased expression of KITLG protein CTD PMID:20531411 gemcitabine multiple interactions ISO RGD:737118 6480464 [Gemcitabine co-treated with Erlotinib Hydrochloride] affects the expression of KITLG protein CTD PMID:24979617 genistein multiple interactions ISO RGD:737118 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KITLG mRNA CTD PMID:27424125 genistein 7-O-beta-D-glucoside multiple interactions ISO RGD:737118 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KITLG mRNA CTD PMID:27424125 gentamycin decreases expression ISO RGD:3086 6480464 Gentamicins results in decreased expression of KITLG mRNA CTD PMID:22061828 glycitein multiple interactions ISO RGD:737118 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KITLG mRNA CTD PMID:27424125 glycitin multiple interactions ISO RGD:737118 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of KITLG mRNA CTD PMID:27424125 gold atom decreases expression ISO RGD:737118 6480464 Gold results in decreased expression of KITLG mRNA CTD PMID:25523186 gold(0) decreases expression ISO RGD:737118 6480464 Gold results in decreased expression of KITLG mRNA CTD PMID:25523186 hexamethylene diisocyanate affects expression ISO RGD:737118 6480464 1, 6-hexamethylene diisocyanate affects the expression of KITLG mRNA CTD PMID:19110044 hydrogen peroxide affects expression ISO RGD:737118 6480464 Hydrogen Peroxide affects the expression of KITLG mRNA CTD PMID:20044591 hydroquinone increases expression ISO RGD:737118 6480464 hydroquinone results in increased expression of KITLG mRNA CTD PMID:22960397 Indeno[1,2,3-cd]pyrene decreases expression EXP 6480464 indeno(1 more ... CTD PMID:26377693 indometacin multiple interactions ISO RGD:737118 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KITLG mRNA CTD PMID:28628672 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of KITL gene CTD PMID:20938992 lead diacetate multiple interactions ISO RGD:737118 6480464 [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of KITLG mRNA CTD PMID:22839698 lead diacetate increases expression ISO RGD:737118 6480464 lead acetate results in increased expression of KITLG mRNA CTD PMID:22839698 lead(0) affects expression ISO RGD:737118 6480464 Lead affects the expression of KITLG mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:737118 6480464 Lead affects the expression of KITLG mRNA CTD PMID:28903495 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of KITL mRNA CTD PMID:12057914 lipopolysaccharide multiple interactions ISO RGD:737118 6480464 [nickel chloride co-treated with Lipopolysaccharides] results in increased secretion of KITLG protein more ... CTD PMID:18437699 , PMID:35811015 LY294002 multiple interactions ISO RGD:737118 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of TFRC protein] CTD PMID:21915944 melphalan decreases expression ISO RGD:737118 6480464 Melphalan results in decreased expression of KITLG mRNA CTD PMID:22363485 mercury dibromide increases expression ISO RGD:737118 6480464 mercuric bromide results in increased expression of KITLG mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:737118 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KITLG mRNA CTD PMID:27188386 methotrexate decreases expression ISO RGD:737118 6480464 Methotrexate results in decreased expression of KITLG mRNA CTD PMID:17400583 methotrexate increases expression ISO RGD:737118 6480464 Methotrexate results in increased expression of KITLG mRNA CTD PMID:24449571 methylisothiazolinone increases expression ISO RGD:737118 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of KITLG mRNA CTD PMID:31629900 microcystin-LR multiple interactions ISO RGD:3086 6480464 [Dietary Fats co-treated with Cholesterol, Dietary co-treated with cyanoginosin LR] results in increased expression of KITLG mRNA CTD PMID:34740672 N,N-diethyl-m-toluamide multiple interactions ISO RGD:3086 6480464 [Permethrin co-treated with DEET] results in decreased methylation of KITLG gene CTD PMID:33148267 N-acetyl-L-cysteine multiple interactions ISO RGD:737118 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased secretion of KITLG protein] CTD PMID:26138014 N-methyl-N'-nitro-N-nitrosoguanidine decreases expression ISO RGD:3086 6480464 Methylnitronitrosoguanidine results in decreased expression of KITLG mRNA CTD PMID:15120970 N-methyl-N-nitrosourea decreases expression EXP 6480464 Methylnitrosourea results in decreased expression of KITL mRNA CTD PMID:18675455 N-methyl-N-nitrosourea multiple interactions EXP 6480464 Quercetin inhibits the reaction [Methylnitrosourea results in decreased expression of KITL mRNA] CTD PMID:18675455 nickel dichloride decreases secretion ISO RGD:737118 6480464 nickel chloride results in decreased secretion of KITLG protein CTD PMID:18437699 nickel dichloride multiple interactions ISO RGD:737118 6480464 [nickel chloride co-treated with Lipopolysaccharides] results in increased secretion of KITLG protein CTD PMID:18437699 nickel sulfate decreases expression ISO RGD:737118 6480464 nickel sulfate results in decreased expression of KITLG mRNA CTD PMID:22714537 nitrofen increases expression ISO RGD:3086 6480464 nitrofen results in increased expression of KITLG mRNA, nitrofen results in increased expression of KITLG protein CTD PMID:26932254 Nutlin-3 increases expression ISO RGD:737118 6480464 nutlin 3 results in increased expression of KITLG mRNA, nutlin 3 results in increased expression of KITLG protein CTD PMID:19098008 ochratoxin A decreases expression ISO RGD:3086 6480464 ochratoxin A results in decreased expression of KITLG mRNA CTD PMID:12700408 oxaliplatin increases expression ISO RGD:3086 6480464 oxaliplatin results in increased expression of KITLG mRNA CTD PMID:25729387 oxaliplatin multiple interactions ISO RGD:3086 6480464 [oxaliplatin co-treated with Topotecan] affects the expression of KITLG mRNA CTD PMID:25729387 oxymetholone increases expression ISO RGD:737118 6480464 Oxymetholone results in increased expression of KITLG mRNA, Oxymetholone results in increased expression of KITLG protein CTD PMID:15953861 ozone decreases expression EXP 6480464 Ozone results in decreased expression of KITL mRNA CTD PMID:12763052 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of KITL mRNA CTD PMID:34911549 p-menthan-3-ol multiple interactions ISO RGD:3086 6480464 [Tobacco Smoke Pollution co-treated with Menthol] results in increased expression of and results in increased secretion of KITLG protein CTD PMID:27818348 panobinostat increases expression ISO RGD:737118 6480464 panobinostat results in increased expression of KITLG mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:737118 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KITLG mRNA CTD PMID:27188386 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of KITL mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:3086 6480464 Acetaminophen results in increased expression of KITLG mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:737118 6480464 Acetaminophen results in increased expression of KITLG mRNA CTD PMID:21420995 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of KITL mRNA CTD PMID:12594235 , PMID:18467506 paracetamol decreases response to substance EXP 6480464 KITL protein results in decreased susceptibility to Acetaminophen CTD PMID:12594235 , PMID:18467506 paracetamol multiple interactions EXP 6480464 KITL protein inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein] more ... CTD PMID:12594235 , PMID:18467506 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of KITL protein CTD PMID:12594235 PCB138 affects expression ISO RGD:737118 6480464 2 more ... CTD PMID:21703328 perfluorooctanoic acid increases expression ISO RGD:737118 6480464 perfluorooctanoic acid results in increased expression of KITLG mRNA CTD PMID:23146750 perfluorooctanoic acid decreases expression ISO RGD:737118 6480464 perfluorooctanoic acid results in decreased expression of KITLG mRNA CTD PMID:32068100 permethrin multiple interactions ISO RGD:3086 6480464 [Permethrin co-treated with DEET] results in decreased methylation of KITLG gene CTD PMID:33148267 phencyclidine increases expression EXP 6480464 Phencyclidine results in increased expression of KITL mRNA CTD PMID:12105081 phenobarbital increases expression ISO RGD:3086 6480464 Phenobarbital results in increased expression of KITLG mRNA CTD PMID:12832660 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of KITL mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:737118 6480464 Phenylmercuric Acetate results in increased expression of KITLG mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:737118 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KITLG mRNA CTD PMID:27188386 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of KITL mRNA CTD PMID:17426115 potassium chromate decreases expression ISO RGD:737118 6480464 potassium chromate(VI) results in decreased expression of KITLG mRNA CTD PMID:22714537 pravastatin affects expression EXP 6480464 Pravastatin affects the expression of KITL mRNA CTD PMID:27225895 pravastatin increases expression ISO RGD:3086 6480464 Pravastatin results in increased expression of KITLG mRNA CTD PMID:27225895 quercetin multiple interactions ISO RGD:737118 6480464 Quercetin inhibits the reaction [[lysophosphatidic acid co-treated with KITLG protein co-treated with EPO protein] results in increased expression of GATA1 mRNA] more ... CTD PMID:21915944 quercetin multiple interactions ISO RGD:3086 6480464 Quercetin inhibits the reaction [Atrazine results in decreased expression of KITLG mRNA] CTD PMID:22372587 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Methylnitrosourea results in decreased expression of KITL mRNA] CTD PMID:18675455 quercetin decreases expression ISO RGD:737118 6480464 Quercetin results in decreased expression of KITLG mRNA CTD PMID:23727915 resveratrol multiple interactions ISO RGD:737118 6480464 resveratrol results in increased activity of [KITL protein co-treated with THPO protein co-treated with FLT3LG protein co-treated with IL6 protein] CTD PMID:26160960 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:737118 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of KITLG mRNA CTD PMID:35811015 SB 203580 decreases expression EXP 6480464 SB 203580 results in decreased expression of SCF protein CTD PMID:15585325 SB 431542 multiple interactions ISO RGD:737118 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:737118 6480464 Silicon Dioxide analog results in decreased expression of KITLG mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:737118 6480464 Silicon Dioxide analog results in increased expression of KITLG mRNA CTD PMID:23806026 silver atom decreases expression EXP 6480464 Silver results in decreased expression of KITL mRNA CTD PMID:27131904 silver(0) decreases expression EXP 6480464 Silver results in decreased expression of KITL mRNA CTD PMID:27131904 silver(1+) nitrate increases expression ISO RGD:737118 6480464 Silver Nitrate results in increased expression of KITLG mRNA CTD PMID:22831968 sirolimus multiple interactions EXP 6480464 Sirolimus inhibits the reaction [KITL protein results in increased expression of CCND3 protein], Sirolimus inhibits the reaction [KITL protein results in increased phosphorylation of RB1 protein] CTD PMID:10849422 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of KITL mRNA CTD PMID:16014739 sodium dichromate increases expression ISO RGD:3086 6480464 sodium bichromate results in increased expression of KITLG mRNA CTD PMID:22561333 sunitinib decreases expression ISO RGD:737118 6480464 Sunitinib results in decreased expression of KITLG mRNA CTD PMID:31533062 T-2 toxin decreases expression EXP 6480464 T-2 Toxin results in decreased expression of KITLG mRNA, T-2 Toxin results in decreased expression of KITLG protein CTD PMID:26314264 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of KITL mRNA CTD PMID:17484886 tetraphene decreases expression EXP 6480464 benz(a)anthracene results in decreased expression of KITL mRNA CTD PMID:26377693 tetraphene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KITL mRNA CTD PMID:27858113 thioacetamide increases expression ISO RGD:3086 6480464 Thioacetamide results in increased expression of KITLG mRNA CTD PMID:34492290 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of KITL mRNA CTD PMID:23557971 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KITL mRNA CTD PMID:29950665 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of KITL mRNA CTD PMID:29264374 toluene 2,4-diisocyanate decreases expression EXP 6480464 Toluene 2, 4-Diisocyanate results in decreased expression of KITL mRNA CTD PMID:21404309 topotecan increases expression ISO RGD:3086 6480464 Topotecan results in increased expression of KITLG mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:3086 6480464 [oxaliplatin co-treated with Topotecan] affects the expression of KITLG mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:737118 6480464 torcetrapib results in increased expression of KITLG mRNA CTD PMID:23228038 trichostatin A increases expression ISO RGD:737118 6480464 trichostatin A results in increased expression of KITLG mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:737118 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KITLG mRNA CTD PMID:27188386 trimellitic anhydride decreases expression EXP 6480464 trimellitic anhydride results in decreased expression of KITL mRNA CTD PMID:19042947 trimellitic anhydride affects expression ISO RGD:737118 6480464 trimellitic anhydride affects the expression of KITLG mRNA CTD PMID:19110044 trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of KITL mRNA CTD PMID:35537566 urethane increases expression ISO RGD:737118 6480464 Urethane results in increased expression of KITLG mRNA CTD PMID:28818685 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of KITL mRNA CTD PMID:17292431 valproic acid multiple interactions ISO RGD:737118 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KITLG mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:737118 6480464 Valproic Acid results in increased expression of KITLG mRNA CTD PMID:19101580 more ... vinclozolin increases expression ISO RGD:3086 6480464 vinclozolin results in increased expression of KITLG mRNA CTD PMID:23034163 , PMID:30207508 vorinostat increases expression ISO RGD:737118 6480464 vorinostat results in increased expression of KITLG mRNA CTD PMID:26272509 , PMID:27188386 vorinostat multiple interactions ISO RGD:737118 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KITLG mRNA CTD PMID:27188386 wortmannin multiple interactions EXP 6480464 wortmannin inhibits the reaction [KITL protein results in increased expression of CCND3 protein], wortmannin inhibits the reaction [KITL protein results in increased phosphorylation of RB1 protein] CTD PMID:10849422 wortmannin multiple interactions ISO RGD:737118 6480464 wortmannin inhibits the reaction [[IL3 protein co-treated with CSF2 protein co-treated with FLT3LG protein co-treated with KITLG protein] results in increased expression of LAT2 protein] more ... CTD PMID:23001822 zaragozic acid A decreases expression ISO RGD:3086 6480464 squalestatin 1 results in decreased expression of KITLG mRNA CTD PMID:27225895 zaragozic acid A affects expression EXP 6480464 squalestatin 1 affects the expression of KITL mRNA CTD PMID:27225895 zearalenone decreases expression ISO RGD:737118 6480464 Zearalenone results in decreased expression of KITLG mRNA CTD PMID:27757495 zinc atom decreases expression ISO RGD:737118 6480464 Zinc results in decreased expression of KITLG mRNA CTD PMID:18316168 zinc protoporphyrin multiple interactions ISO RGD:737118 6480464 [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of KITLG mRNA CTD PMID:22839698 zinc(0) decreases expression ISO RGD:737118 6480464 Zinc results in decreased expression of KITLG mRNA CTD PMID:18316168 zoledronic acid decreases expression ISO RGD:737118 6480464 zoledronic acid results in decreased expression of KITLG mRNA CTD PMID:24714768
